[1]Marumoto T, Tashiro A, Friedmann-Morvinski D, et al, Development of a novel mouse glioma model using lentiviral vectors[J]. Nat Med, 2009, 15(1): 110-116.
[2]Stojiljkovic M, Piperski V, Dacevic M, et al, Characterization of 9L glioma model of the Wistar rat[J]. J Neurooncol, 2003, 63(1): 1-7.
[3]Jiang HY, Cai YY.Effectiveness assessment of teaching method based on system dynamics for health policies[J]. Journal of Shanghai Jiaotong University(Medical Science), 2015, 35(1): 123-127. (in Chinese)
江浩艳,蔡雨阳. 基于系统动力学的卫生政策教学效果评价[J]. 上海交通大学学报医学版, 2015, 35(1): 123-127.
[4]Holland EC. Gliomagenesis: genetic alterations and mouse models[J]. Nat Rev Genet, 2001, 2(2): 120-129.
[5]Hesselager G, Holland EC. Using mice to decipher the molecular genetics of brain tumors[J]. Neurosurgery, 2003, 53(3): 685-695.
[6]Shan GJ, Yuan JL, Chen J. Microsurgical Anatomy and surgical technique relative to treatment of gliomas located in lateral fissure area[J]. Journal of Oncology,2006, 12(2):121-123. (in Chinese)
单国进, 袁坚列, 陈杰. 侧裂区胶质瘤的相关手术解剖与手术技巧[J]. 肿瘤学杂志,2006, 12(2):121-123.
[7]Watanabe K, Tachibana O, Sata K, et al, Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas[J]. Brain Pathol, 1996, 6(3): 217-224.
[8]Guha A, Feldkamp MM, Lau N, et al, Proliferation of human malignant astrocytomas is dependent on Ras activation[J]. Oncogene, 1997, 15(23): 2755-2765.
[9]Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q233 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997, 15(4): 356-362.
[10]Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer[J]. Science, 1997, 275(5308): 1943-1947. |